Establishing secure connection…Loading editor…Preparing document…

Research Consortium Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH CONSORTIUM AGREEMENT

This Research Consortium Agreement (the Agreement) is entered into by and between Lead Institution: and Consortium Member: .

WHEREAS

WHEREAS, the parties desire to collaborate on research activities described herein for the purpose of advancing scientific knowledge and developing potential applications arising from the collaborative research; and

WHEREAS, each party will contribute specific resources, personnel, and data as set forth in this Agreement and the Scope of Work, and each party seeks to establish terms for allocation of costs, management of intellectual property, confidentiality, publication, and termination; and

WHEREAS, the parties intend that this Agreement define responsibilities, funding arrangements, and governance of the Consortium to minimize disputes and ensure timely performance.

PARTIES' CONTACT & ADDRESSES

SCOPE OF WORK

The parties shall undertake, in accordance with the terms and schedules set forth in this Agreement, the collaborative research tasks described below. Each party shall perform its respective tasks in good faith, using qualified personnel and in accordance with accepted scientific standards.

PAYMENT TERMS

Consortium funding and cost-sharing shall be as follows. Lead Institution shall invoice Consortium Member as set forth below and each party shall remit payments in accordance with the schedule. Payment obligations are subject to availability of appropriated funds and the party’s internal approval processes.

If any undisputed payment is not received within days after the due date, late payments shall accrue interest at percent per month (or the maximum rate permitted by law, if lower), calculated monthly on the outstanding balance until paid in full.

TERM AND TERMINATION

This Agreement shall commence on the Effective Date and continue in effect until the Term End Date unless earlier terminated in accordance with this Section.

Effective Date:     Term End Date:

Either party may terminate this Agreement for cause if the other party materially breaches any provision and fails to cure such breach within days after receipt of written notice. Either party may also terminate for convenience upon written notice in accordance with the notice provisions below; termination for convenience shall not relieve the terminating party of obligations accrued through the effective date of termination, and the parties shall cooperate to wind down activities in an orderly manner.

CONFIDENTIALITY

Each party may disclose Confidential Information to the other party in connection with the Scope of Work. "Confidential Information" means nonpublic technical, scientific, business, financial or other information clearly identified as confidential at the time of disclosure. Receiving party shall: (a) hold Confidential Information in confidence using at least the same degree of care it uses to protect its own confidential information but no less than reasonable care; (b) use Confidential Information solely to perform its obligations or exercise rights under this Agreement; and (c) not disclose Confidential Information to third parties except as permitted herein.

Confidential Information does not include information that: (i) is or becomes publicly available other than by breach of this Agreement; (ii) was lawfully in the receiving party’s possession prior to disclosure by the disclosing party; (iii) is received from a third party without breach of an obligation of confidentiality; or (iv) is independently developed by the receiving party without use of the disclosing party’s Confidential Information. Receiving party may disclose Confidential Information to its employees, agents, and contractors who have a need to know and who are bound by confidentiality obligations at least as protective as those set forth in this Agreement.

INTELLECTUAL PROPERTY AND PUBLICATION

Unless otherwise expressly agreed in writing, background intellectual property owned or controlled by a party prior to the Effective Date shall remain the sole property of that party. Intellectual property developed jointly shall be owned jointly in proportion to each party’s inventive contribution, unless the parties agree otherwise in writing. Parties shall confer in good faith regarding publication of results; no party shall unreasonably withhold approval for publication, provided that drafts containing Confidential Information of another party shall be submitted for review at least 30 days prior to submission for publication to permit redaction of Confidential Information or filing of patent applications.

INDEMNIFICATION AND LIABILITY

Each party shall defend, indemnify and hold harmless the other party from third-party claims arising out of its negligent acts or willful misconduct in the performance of this Agreement. Neither party shall be liable for consequential, incidental, punitive, or special damages except to the extent resulting from gross negligence or willful misconduct.

NOTICES

All notices required or permitted under this Agreement shall be in writing and delivered to the addresses set forth below or to such other address as a party may designate in writing:

GOVERNING LAW

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of law principles. The parties submit to the exclusive jurisdiction of the courts located in that State for disputes not resolved by negotiation or mediation.

ENTIRE AGREEMENT

This Agreement, together with any exhibits or schedules expressly incorporated herein, constitutes the entire agreement between the parties with respect to the subject matter and supersedes all prior and contemporaneous understandings, agreements, representations and warranties, both written and oral. Any amendment or modification must be in writing and signed by authorized representatives of both parties.

SEVERABILITY

If any provision of this Agreement is held to be invalid, illegal or unenforceable, the remaining provisions shall continue in full force and effect and the parties shall negotiate in good faith to replace the invalid provision with a valid provision that achieves, to the extent possible, the original intent of the parties.

Lead Institution:

By:

Date:

Consortium Member:

By:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What a Research Consortium Agreement Is and When It’s Used

A Research Consortium Agreement is a formal written contract between two or more institutions, organizations, or investigators that sets out roles, responsibilities, funding, intellectual property rights, data sharing terms, publication and authorship rules, confidentiality, and liability allocation for a collaborative research project. It governs how the parties will cooperate, how resources and budgets are managed, and how project outputs—including inventions and datasets—are owned, licensed, and disseminated. These agreements are commonly used for multi-institution grants, cross-sector partnerships, federally funded studies, and multi-site clinical or translational research programs to reduce ambiguity and manage compliance risks.

Why a Clear Consortium Agreement Matters

A well-drafted Research Consortium Agreement establishes governance, reduces disputes, clarifies IP and data ownership, and helps satisfy sponsor and institutional compliance requirements such as federal award terms, HIPAA, and human subjects protections. It provides a predictable framework for decision-making and risk allocation across diverse partners.

Why a Clear Consortium Agreement Matters

Who Typically Prepares and Signs These Agreements

Institutions and project leaders prepare or request consortium agreements when collaborative work crosses organizational boundaries.

  • Lead investigators and principal investigators responsible for project delivery and technical coordination between partners.
  • Sponsored research offices, grants administrators, and university counsel who negotiate funding terms and institutional obligations.
  • Industry partners, nonprofit organizations, or government agencies that provide funding, materials, or technical support to the consortium.

Signatures usually include authorized institutional signatories; delegated signature authority should be verified before execution.

Key Signatories and Their Roles

Principal Investigator

Leads the scientific program, manages project execution, and certifies compliance with human subjects, biosafety, and sponsor terms. The PI typically approves the technical scope, milestones, and resource allocations and coordinates IRB or IACUC approvals across sites.

Authorized Institutional Signatory

An administrative or legal officer with delegated authority to bind the institution contractually. This signatory confirms institutional commitments for budget, indemnity, IP assignment, and compliance obligations and should be listed with title and signing authority documentation.

Essential Information to Include

Party Names: Full legal entity names
Principal Investigators: Full name and institutional role
Effective Date: MM/DD/YYYY format
Project Scope: Brief project summary
Funding Terms: Amounts and payment schedule
Governing Law: State chosen for disputes

Primary Risks and Potential Consequences

Breach of Contract: Damages, injunctive relief
Loss of Funding: Sponsor termination risk
HIPAA Violations: Civil penalties, BAA issues
IP Disputes: Litigation or lost rights
Regulatory Noncompliance: Suspension of research
Data Exposure: Reputational harm, fines

Common Mistakes to Avoid

  • Failing to identify the correct legal entity names and signing authority, which can render a signature ineffective and delay execution for weeks or months.
  • Leaving intellectual property and licensing terms vague, creating downstream disputes over ownership and commercialization rights that are costly to resolve.
  • Neglecting data privacy and security provisions such as HIPAA, de-identification standards, or data transfer mechanisms, which can trigger regulatory penalties.
  • Omitting a clear dispute resolution, governance, or termination clause, resulting in protracted disagreements and uncertain exit paths for partners.

Real-World Consortium Scenarios

Two short examples illustrate how parties structure consortium agreements to manage IP, data, and compliance across institutions.

Academic–Industry Collaboration

A university and a biotech company formed a five-party consortium to co-develop diagnostics, sharing preclinical data under tiered access.

  • The industry partner funded milestones tied to deliverables and retained commercialization rights for certain patents.
  • Parties used milestone-based payments, assigned background IP to originating institutions, and negotiated a royalty-sharing scheme for newly created intellectual property to balance academic publication and commercial interests.

Multi-Site Clinical Study

A consortium of hospitals coordinated a multi-site clinical trial with centralized data management and a single IRB reliance agreement.

  • Data use agreements defined permitted analysis and sharing with external collaborators.
  • The agreement required uniform consent language, assigned data custodianship, specified publication review periods, and established a steering committee to resolve scientific and authorship disputes.

Step-by-Step: Preparing and Executing the Agreement

Follow these sequential steps to draft, review, and finalize a Research Consortium Agreement with clear responsibilities and execution controls.

  • 01
    Draft Scope: Describe objectives, tasks, and deliverables.
  • 02
    Negotiate Terms: Agree on IP, data, and funding allocation.
  • 03
    Obtain Approvals: Secure institutional, IRB, and legal sign-off.
  • 04
    Execute: Authorized signatories sign and exchange copies.

How to Configure an Online Signing Workflow

Set up a controlled e-signature workflow so authorized users can execute the agreement securely and reliably.

Workflow Step | Online Setting Role assignment | Field-level signer roles
Upload Agreement PDF or DOCX upload; set version control
Assign Roles Designate signers and order of signing
Add Signature Fields Place signature, date, and initials
Set Authentication Email, SMS code, or advanced auth

Typical Routing and Submission Flow

A concise eSubmission flow ensures each party receives the correct version and audit trail.

  • Upload and Tag: Upload final PDF, tag fields per signer
  • Auth and Notify: Authenticate signers, send invites
  • Sign and Timestamp: Signers complete fields and date
  • Archive and Distribute: Store executed copy and shared certificate

Core Clauses to Include in a Professional Agreement

A comprehensive Research Consortium Agreement covers governance, IP, data, confidentiality, funding, and dispute resolution to reduce ambiguity and support compliance.

Governance

Define a steering committee, decision-making authority, voting thresholds, and escalation procedures so partners have a predictable process for resolving scientific and administrative disputes.

Intellectual Property

Allocate ownership of background IP and newly created IP, specify invention disclosure procedures, patent prosecution responsibilities, and licensing or royalty-sharing mechanisms for commercialization.

Data Management

Describe data stewardship, permitted uses, de-identification standards, data access controls, and procedures for data sharing or third-party requests to maintain privacy and reproducibility.

Funding & Budget

Detail payment schedules, allowable costs, invoicing, expense reporting, and handling of grant shortfalls or budget reallocations to prevent financial disputes.

Confidentiality

Define confidential information, permitted disclosures, duration of confidentiality obligations, and carve-outs for required disclosures to ensure appropriate protection of proprietary data.

Publication & Authorship

Specify manuscript review periods, authorship criteria, pre-publication review rights, and procedures to resolve disputes to preserve academic integrity and sponsor interests.

Digital Signing and Technical Considerations

Use an eSignature platform that supports required authentication, audit trails, and document formats to meet institutional and sponsor needs.

  • Supported Formats: PDF, DOCX, and secure HTML
  • Integrations: Salesforce, NetSuite, Google Workspace
  • Security Standards: AES-256 at rest, TLS in transit

Confirm platform HIPAA or 21 CFR Part 11 needs, signatory authentication methods, and audit-trail export options before executing institutional agreements.

Comparing eSignature Providers for Consortium Agreement Workflows

Vendor pricing and feature coverage vary; the table summarizes common decision criteria with signNow listed first for easy comparison.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies Varies Varies Varies
Bulk Send Yes Yes Yes Yes Yes
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Practical Tips for Accurate and Efficient Agreements

Adopt consistent templates and review workflows to reduce negotiation time and ensure compliance across partners.

Use a Master Template with Exhibits
Maintain a single institutional template that addresses common issues (IP, data, indemnity) and attach project-specific exhibits to cover technical scope and budget, reducing repeat legal review time.
Confirm Signature Authority Early
Request evidence of delegated signature authority or a corporate resolution before finalizing language to prevent re-execution and administrative delays.
Align Consent and IRB Language
Coordinate human subjects consent forms and IRB reliance agreements across sites during negotiation to avoid conflicting obligations that could suspend enrollment or invalidate data.
Preserve Audit Trails
Use eSignature platforms that capture timestamps, IP addresses, and access logs, and retain certificates of completion for the retention period to support audits or disputes.

Typical Deadlines and Reporting Expectations

Consortium agreements commonly specify execution and reporting milestones tied to funding and compliance obligations.

Execution Deadline:

Complete signed agreement before release of first payment

IRB Approval Deadline:

Obtain required IRB approvals prior to enrolling participants

Interim Reports:

Submit progress reports per sponsor schedule

Data Submission:

Deliver datasets by agreed milestone dates

Final Reporting:

File final scientific and financial reports per award terms

Common Questions About Execution, Validity, and Compliance

Answers to frequent questions about enforceability, signatures, data protection, and corrections when working with consortium agreements.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.